High LET heavy ion radiation induces p53-independent apoptosis

Journal of Radiation Research

Volumn 50, Issue 1, 2009, Pages 37-42

  Mori, Eiichiro ^a   Takahashi, Akihisa ^a   Yamakawa, Nobuhiro ^a   Kirita, Tadaaki ^a   Ohnishi, Takeo ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; DISEASES; ENERGY TRANSFER; HEAVY IONS; RADIATION EFFECTS;

CANCER THERAPY; CELL TYPES; CELLULARS; CLINICAL TREATMENTS; HIGH LINEAR ENERGY TRANSFERS; HUMAN CANCER; ION RADIATION; LOW LINEAR ENERGY TRANSFERS; P53 GENE; THERAPEUTIC STRATEGY;

CELL DEATH;

EID: 62549147063     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.08075     Document Type: Article

References (58)

1. Blakely, E. A. and Kronenberg, A. (1998) Heavy-ion radiobiology: new approaches to delineate mechanisms underlying enhanced biological effectiveness. Radiat. Res. 150: S126-S145.
2. Demizu, Y., Kagawa, K., Ejima, Y., Nishimura, H., Sasaki, R., Soejima, T., Yanou, T., Shimizu, M., Furusawa, Y., Hishikawa, Y. and Sugimura, K. (2004) Cell biological basis for combination radiotherapy using heavy-ion beams and high-energy X-rays. Radiother. Oncol. 71: 207-211.
3. Debus, J., Jäckel, O., Kraft, G. and Wannenmacher, M. (1998) Is there a role for heavy ion beam therapy? Recent Results Cancer Res. 150: 170-182.
4. Nakano, T., Suzuki, Y., Ohno, T., Kato, S., Suzuki, M., Morita, S., Sato, S., Oka, K. and Tsujii, H. (2006) Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia. Clin. Cancer Res. 12: 2185-2190.
5. Matsufuji, N., Kanai, T., Kanematsu, N., Miyamoto, T., Baba, M., Kamada, T., Kato, H., Yamada, S., Mizoe, J. E. and Tsujii, H. (2007) Specification of carbon ion dose at the National Institute of Radiological Sciences (NIRS). J. Radiat. Res. 48: A81-A86.
6. Hamada, N., Hara, T., Omura-Minamisawa, M., Funayama, T., Sakashita, T., Sora, S., Yokota, Y., Nakano, T. and Kobayashi, Y. (2008) Energetic heavy ions overcome tumor radioresistance caused by overexpression of Bcl-2. Radiother. Oncol. 89: 231-236.
7. Masunaga, S., Ando, K., Uzawa, A., Hirayama, R., Furusawa, Y., Koike, S., Sakurai, Y., Nagata, K., Suzuki, M., Kashino, G., Kinashi, Y., Tanaka, H., Maruhashi, A. and Ono, K. (2008) Radiobiologic significance of response of intratumor quiescent cells in vivo to accelerated carbon ion beams compared with γ-rays and reactor neutron beams. Int. J. Radiat. Oncol. Biol. Phys. 70: 221-228.
8. Chen, G. T., Castro, J. R. and Quivey, J. M. (1981) Heavy charged particle radiotherapy. Ann. Rev. Biophys. Bioeng. 10: 499-529.
9. Kraft, G. (2000) Tumor therapy with heavy charged particles. Prog. Part. Nucl. Phys. 45: S473-S544.
10. Schulz-Ertner, D., Jäkel, O. and Schlegel, W. (2006) Radiation therapy with charged particles. Semin. Radiat. Oncol. 16: 249-259.
11. Schulz-Ertner, D. and Tsujii, H. (2007) Particle radiation therapy using proton and heavier ion beams. J. Clin. Oncol. 25: 953-964.
12. Tsujii, H., Mizoe, J., Kamada, T., Baba, M., Tsuji, H., Kato, H., Kato, S., Yamada, S., Yasuda, S., Ohno, T., Yanagi, T., Imai, R., Kagei, K., Kato, H., Hara, R., Hasegawa, A., Nakajima, M., Sugane, N., Tamaki, N., Takagi, R., Kandatsu, S., Yoshikawa, K., Kishimoto, R. and Miyamoto, T. (2007) Clinical results of carbon ion radiotherapy at NIRS. J. Radiat. Res. 48: A1-A13.
13. Lee, J. and Bernstein, A. (1993) p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA 90: 5742-5746.
14. McIlwrath, A. J., Vasey, P. A., Ross, G. M. and Brown, R. (1994) Cell cycle arrests and radiosensitivity of human tumor cell lines dependence on wild-type p53 for radiosensitivity. Cancer Res. 54: 3718-3722.
15. Bristow, R. G., Jang, A., Peacock, J., Chung, S., Benchimol, S. and Hill, R. P. (1994) Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. Oncogene 9: 1527-1536.
16. Pardo, F. S., Su, M., Borek, C., Preffer, F., Dombkowski, D., Gerweck, L. and Schmidt, E. V. (1994) Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance. Radiat. Res. 140: 180-185.
17. 1 checkpoint is retained in tumorigenic rat embryo fibroblast clones transformed by the human papillomavirus type 16 E7 gene and EJ-ras. Mol. Cell. Biol. 15: 1446-1454.
18. Tsuboi, K., Tsuchida, Y., Nose, T. and Ando, K. (1998) Cytotoxic effect of accelerated carbon beams on glioblastoma cell line with p53 mutation clonogenic survival and cell-cycle analysis. Int. J. Radiat. Oncol. Biol. Phys. 74: 71-79.
19. Lane, D. (1992) p53, guardian of the genome. Nature 358: 15-16.
20. Vousden, K. H. and Lu, X. (2002) Live or let die: the cell's response to p53. Nat. Rev. Cancer 2: 594-604.
21. Slee, E. A., O'Connor, D. J. and Lu, X. (2004) To die or not to die: how does p53 decide? Oncogene 23: 2809-2818.
22. Efeyan, A. and Serrano, M. (2007) p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 6: 1006-1010.
23. Ohnishi, T., Takahashi, A., Mori, E. and Ohnishi, K. (2008) p53 targeting can enhance cancer therapy via radiation, heat and anti-cancer agents. Anticancer Agents Med. Chem. 8: 564-570.
24. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C. C. (1991) p53 mutations in human cancers. Science 253: 49-53.
25. Lowe, S. W., Ruley, H. E., Jacks, T. and Housman, D. E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967.
26. Kirita, T., Ohnishi, K. and Ohnishi, T. (2001) A new strategy for cancer therapy based on a predictive indicator. Hum. Cell 14: 1-6.
27. Takahashi, A., Ohnishi, K., Ota, I., Asakawa, I., Tamamoto, T., Furusawa, Y., Matsumoto, H. and Ohnishi, T. (2001) p53-dependent thermal enhancement of cellular sensitivity in human squamous cell carcinomas in relation to LET. Int. J. Radiat. Biol. 77: 1043-1051.
28. Asakawa, I., Yoshimura, H., Takahashi, A., Ohnishi, K., Nakagawa, H., Ota, I., Furusawa, Y., Tamamoto, T., Ohishi, H. and Ohnishi, T. (2002) Radiation-induced growth inhibition in transplanted human tongue carcinomas with different p53 gene status. Anticancer Res. 22: 2037-2043.
29. Takahashi, A., Ohnishi, K., Wang, X., Kobayashi, M., Matsumoto, H., Tamamoto, T., Aoki, H., Furusawa, Y., Yukawa, O. and Ohnishi, T. (2000) The dependence of p53 on the radiation enhancement of thermosensitivity at different LET. Int. J. Radiat. Oncol. Biol. Phys. 47: 489-494.
30. Takahashi, A., Matsumoto, H., Yuki, K., Yasumoto, J., Kajiwara, A., Aoki, M., Furusawa, Y., Ohnishi, K. and Ohnishi, T. (2004) High-LET radiation enhanced apoptosis but not necrosis regardless of p53 status. Int. J. Radiat. Oncol. Biol. Phys. 60: 591-597.
31. Takahashi, A., Yano, T., Matsumoto, H., Wang, X., Ohnishi, K., Tamamoto, T., Tsuji, K., Yukawa, O. and Ohnishi, T. (1998) Effects of accelerated carbon-ions on growth inhibition of transplantable human esophageal cancer in nude mice. Cancer Lett. 122: 181-186.
32. Takahashi, A., Yano, T., Matsumoto, H., Wang, X., Ohnishi, K., Tamamoto, T., Tsuji, K., Yukawa, O. and Ohnishi, T. (2005) Apoptosis induced by high-LET radiation is not affected by cellular p53 gene status. Int. J. Radiat. Biol. 81: 581-586.
33. Hunter, A. M., LaCasse, E. C. and Korneluk, R. G. (2007) The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12: 1543-1568.
34. Yamakawa, N., Takahashi, A., Mori, E., Imai, Y., Furusawa, Y., Ohnishi, K., Kirita, T. and Ohnishi, T. (2008) High LET radiation enhances apoptosis in mutated p53 cancer cells through Caspase-9 activation. Cancer Sci. 99: 1455-1460.
35. Wang, J. and Lenardo, M. J. (2000) Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. J. Cell Sci. 113: 753-757.
36. Sun, X. M., MacFarlane, M., Zhuang, J., Wolf, B. B., Green, D. R. and Cohen, G. M. (1999) Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274: 5053-5060.
37. Bratton, S. B., MacFarlane, M., Cain, K. and Cohen, G. M. (2000) Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. Exp. Cell Res. 256: 27-33.
38. Herr, I. and Debatin, K. M. (2001) Cellular stress response and apoptosis in cancer therapy. Blood 98: 2603-2614.
39. Hengartner, M. O. (2000) The biochemistry of apoptosis. Nature 407: 770-776.
40. Yang, S., Kuo, C., Bisi, J. E. and Kim, M. K. (2002) PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2. Nat. Cell Biol. 4: 865-870.
41. Norbury, C. J. and Zhivotovsky, B. (2004) DNA damage-induced apoptosis. Oncogene 23: 2797-2808.
42. Guo, Y., Srinivasula, S. M., Druilhe, A., Fernandes-Alnemri, T. and Alnemri, E. S. (2002) Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J. Biol. Chem. 277: 13430-13437.
43. Lassus, P., Opitz-Araya, X. and Lazebnik, Y. (2002) Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297: 1352-1354.
44. Paroni, G., Henderson, C., Schneider, C. and Brancolini, C. (2002) Caspase-2 can trigger cytochrome c release and apoptosis from the nucleus. J. Biol. Chem. 277: 15147-15161.
45. Robertson, J. D., Enoksson, M., Suomela, M., Zhivotovsky, B. and Orrenius, S. (2002) Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J. Biol. Chem. 277: 29803-29809.
46. Oniscu, A., Sphyris, N., Morris, R. G., Bader, S. and Harrison, D. J. (2004) p73α is a candidate effector in the p53 independent apoptosis pathway of cisplatin damaged primary murine colonocytes. J. Clin. Pathol. 57: 492-498.
47. Ozaki, T. and Nakagawara, A. (2005) p73, a sophisticated p53 family member in the cancer world. Cancer Sci. 96: 729-737.
48. Allan, L. A., Morrice, N., Brady, S., Magee, G., Pathak, S. and Clarke, P. R. (2003) Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat. Cell Biol. 5: 647-654.
49. Martin, M. C., Allan, L. A., Mancini, E. J. and Clarke, P. R. (2008) The docking interaction of caspase-9 with ERK2 provides a mechanism for the selective inhibitory phosphorylation of caspase-9 at threonine 125. J. Biol. Chem. 283: 3854-3865.
50. Brady, S. C., Allan, L. A. and Clarke, P. R. (2005) Regulation of caspase 9 through phosphorylation by protein kinase C zeta in response to hyperosmotic stress. Mol. Cell. Biol. 25: 10543-10555.
51. Raina, D., Pandey, P., Ahmad, R., Bharti, A., Ren, J., Kharbanda, S., Weichselbaum, R. and Kufe, D. (2005) c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage. J. Biol. Chem. 280: 11147-11151.
52. Yang, Y. L. and Li, X. M. (2000) The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res. 10: 169-177.
53. Deveraux, Q. L., Roy, N., Stennicke, H. R., Van Arsdale, T., Zhou, Q., Srinivasula, S. M., Alnemri, E. S., Salvesen, G. S. and Reed, J. C. (1998) IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17: 2215-2223.
54. Datta, R., Oki, E., Endo, K., Biedermann, V., Ren, J. and Kufe, D. (2000) XIAP regulates DNA damage-induced apoptosis downstream of caspase-9 cleavage. J. Biol. Chem. 275: 31733-31738.
55. Morizane, Y., Honda, R., Fukami, K. and Yasuda, H. (2005) X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO. J. Biochem. 137: 125-132.
56. Ohnishi, K., Scuric, Z., Schiestl, R. H., Okamoto, N., Takahashi, A. and Ohnishi, T. (2006) siRNA targeting NBS1or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status. Radiat. Res. 166: 454-462.
57. Ohnishi, K., Nagata, Y., Takahashi, A. and Ohnishi, T. (2008) Effective enhancement of X-ray-induced apoptosis in human cancer cells with mutated p53 by siRNA targeting XIAP. Oncol. Rep. 20: 57-61.
58. National Institute of Radiological Sciences [online]. Accessed 19 June 2008. URL: http://www.nirs.go.jp/ENG/research/charged_particle/index.shtml